Jeff Martin
Stock Analyst at Roth Capital
(4.33)
# 364
Out of 5,142 analysts
66
Total ratings
59.68%
Success rate
15.88%
Average return
Main Sectors:
Stocks Rated by Jeff Martin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSIS OSI Systems | Maintains: Buy | $292 → $295 | $292.89 | +0.72% | 18 | Jan 30, 2026 | |
| BWMN Bowman Consulting Group | Maintains: Buy | $45 → $50 | $33.42 | +49.61% | 6 | Dec 9, 2025 | |
| PERI Perion Network | Reiterates: Buy | $14 → $15 | $9.00 | +61.11% | 10 | Nov 13, 2025 | |
| NSP Insperity | Maintains: Buy | $85 → $74 | $23.30 | +217.60% | 9 | Aug 4, 2025 | |
| FC Franklin Covey Co. | Maintains: Buy | $30 → $27 | $14.92 | +80.97% | 8 | Jul 7, 2025 | |
| TACT TransAct Technologies | Maintains: Buy | $6 → $5 | $3.66 | +36.45% | 1 | May 14, 2025 | |
| BGSF BGSF, Inc. | Maintains: Buy | $12 → $9 | $6.29 | +43.08% | 1 | Mar 20, 2025 | |
| BBSI Barrett Business Services | Maintains: Buy | $43 → $45 | $32.29 | +39.36% | 5 | Nov 7, 2024 | |
| HCKT The Hackett Group | Maintains: Buy | $29 → $30 | $13.96 | +114.90% | 6 | Nov 5, 2024 | |
| GLMD Galmed Pharmaceuticals | Initiates: Buy | $5,760 | $0.54 | +1,064,595.01% | 2 | Nov 15, 2017 |
OSI Systems
Jan 30, 2026
Maintains: Buy
Price Target: $292 → $295
Current: $292.89
Upside: +0.72%
Bowman Consulting Group
Dec 9, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $33.42
Upside: +49.61%
Perion Network
Nov 13, 2025
Reiterates: Buy
Price Target: $14 → $15
Current: $9.00
Upside: +61.11%
Insperity
Aug 4, 2025
Maintains: Buy
Price Target: $85 → $74
Current: $23.30
Upside: +217.60%
Franklin Covey Co.
Jul 7, 2025
Maintains: Buy
Price Target: $30 → $27
Current: $14.92
Upside: +80.97%
TransAct Technologies
May 14, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $3.66
Upside: +36.45%
BGSF, Inc.
Mar 20, 2025
Maintains: Buy
Price Target: $12 → $9
Current: $6.29
Upside: +43.08%
Barrett Business Services
Nov 7, 2024
Maintains: Buy
Price Target: $43 → $45
Current: $32.29
Upside: +39.36%
The Hackett Group
Nov 5, 2024
Maintains: Buy
Price Target: $29 → $30
Current: $13.96
Upside: +114.90%
Galmed Pharmaceuticals
Nov 15, 2017
Initiates: Buy
Price Target: $5,760
Current: $0.54
Upside: +1,064,595.01%